Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

A changing landscape: Temporal trends in incidence and characteristics of patients hospitalized with venous thromboembolism 2006-2015.

Münster AM, Rasmussen TB, Falstie-Jensen AM, Harboe L, Stynes G, Dybro L, Hansen ML, Brandes A, Grove EL, Johnsen SP.

Thromb Res. 2019 Feb 13;176:46-53. doi: 10.1016/j.thromres.2019.02.009. [Epub ahead of print]

PMID:
30776687
2.

Implementation of a Quit Smoking Programme in Community Adult Mental Health Services-A Qualitative Study.

Burns A, Webb M, Stynes G, O'Brien T, Rohde D, Strawbridge J, Clancy L, Doyle F.

Front Psychiatry. 2018 Dec 21;9:670. doi: 10.3389/fpsyt.2018.00670. eCollection 2018.

3.

Patient characteristics and bleeding events in nonvalvular atrial fibrillation patients treated with apixaban or vitamin K antagonists: real-world evidence from Italian administrative databases.

Ramagopalan S, Allan V, Saragoni S, Esposti LD, Alessandrini D, Perrone V, Buda S, Stynes G, Toma C, DeSolda F; a LHUs group.

J Comp Eff Res. 2018 Nov;7(11):1063-1071. doi: 10.2217/cer-2018-0054. Epub 2018 Aug 13.

4.

Initiation and continuation of oral anticoagulant prescriptions for stroke prevention in non-valvular atrial fibrillation: A cohort study in primary care in France.

Collings SL, Vannier-Moreau V, Johnson ME, Stynes G, Lefèvre C, Maguire A, Asmar J, Bizouard G, Duhot D, Mouquet F, Fauchier L.

Arch Cardiovasc Dis. 2018 May;111(5):370-379. doi: 10.1016/j.acvd.2017.10.003. Epub 2018 Feb 3.

PMID:
29398546
5.

Modelling the effect of beliefs about asthma medication and treatment intrusiveness on adherence and preference for once-daily vs. twice-daily medication.

Chapman S, Dale P, Svedsater H, Stynes G, Vyas N, Price D, Horne R.

NPJ Prim Care Respir Med. 2017 Nov 14;27(1):61. doi: 10.1038/s41533-017-0061-7.

6.

Oral anticoagulant persistence in patients with non-valvular atrial fibrillation: A cohort study using primary care data in Germany.

Collings SL, Lefèvre C, Johnson ME, Evans D, Hack G, Stynes G, Maguire A.

PLoS One. 2017 Oct 10;12(10):e0185642. doi: 10.1371/journal.pone.0185642. eCollection 2017.

7.

Thiol surface functionalization via continuous phase plasma polymerization of allyl mercaptan, with subsequent maleimide-linked conjugation of collagen.

Stynes GD, Gengenbach TR, Kiroff GK, Morrison WA, Kirkland MA.

J Biomed Mater Res A. 2017 Jul;105(7):1940-1948. doi: 10.1002/jbm.a.36064. Epub 2017 Apr 3.

PMID:
28294550
8.

Comparative effectiveness of mepolizumab and omalizumab in severe asthma: An indirect treatment comparison.

Cockle SM, Stynes G, Gunsoy NB, Parks D, Alfonso-Cristancho R, Wex J, Bradford ES, Albers FC, Willson J.

Respir Med. 2017 Feb;123:140-148. doi: 10.1016/j.rmed.2016.12.009. Epub 2016 Dec 21. Review.

9.

Surface-bound collagen 4 is significantly more stable than collagen 1.

Stynes GD, Kiroff GK, Page RS, Morrison WA, Kirkland MA.

J Biomed Mater Res A. 2017 May;105(5):1364-1373. doi: 10.1002/jbm.a.36019. Epub 2017 Feb 24.

PMID:
28130865
10.

Once-daily fluticasone furoate/vilanterol versus twice daily combination therapies in asthma-mixed treatment comparisons of clinical efficacy.

Svedsater H, Stynes G, Wex J, Frith L, Leather D, Castelnuovo E, Detry M, Berry S.

Asthma Res Pract. 2016 Feb 8;2:4. doi: 10.1186/s40733-015-0016-0. eCollection 2016.

11.

Rigid removable cover for dorsal wound protection and tube fixation in pigs.

Stynes GD, Kiroff GK, Morrison WA, Edwards GA, Page RS, Kirkland MA.

Aust Vet J. 2016 Apr;94(4):111-6. doi: 10.1111/avj.12424.

PMID:
27021892
12.

Toward a skin-material interface with vacuum-integrated capped macroporous scaffolds.

Stynes GD, Kiroff GK, Morrison WA, Page RS, Kirkland MA.

J Biomed Mater Res B Appl Biomater. 2017 Jul;105(5):1307-1318. doi: 10.1002/jbm.b.33649. Epub 2016 Mar 10.

PMID:
26968747
13.

Once-daily fluticasone furoate/vilanterol 100/25 mcg versus twice daily combination therapies in COPD - mixed treatment comparisons of clinical efficacy.

Stynes G, Svedsater H, Wex J, Lettis S, Leather D, Castelnuovo E, Detry M, Berry S.

Respir Res. 2015 Feb 15;16:25. doi: 10.1186/s12931-015-0184-8. Review.

14.

Cost-Minimization and Budget-Impact Analysis of Fixed-Dose ICS/LABA Combination Inhalers in the Treatment of Asthma in Slovenia.

Hren R, Trkman M, Stynes G.

Value Health. 2014 Nov;17(7):A592. doi: 10.1016/j.jval.2014.08.2031. Epub 2014 Oct 26. No abstract available.

15.

Cost-Minimization and Budget-Impact Analysis of Fixed-Dose Combination Inhalers in Treatment of Copd in Slovenia.

Hren R, Stynes G.

Value Health. 2014 Nov;17(7):A592. doi: 10.1016/j.jval.2014.08.2032. Epub 2014 Oct 26. No abstract available.

16.

Laboratory research facilities and hospitals: an anachronism in 21st century Australia?

Stynes G, Kiroff GK.

ANZ J Surg. 2010 Sep;80(9):580-1. Review. No abstract available.

PMID:
20857610
17.

Tissue compatibility of biomaterials: benefits and problems of skin biointegration.

Stynes G, Kiroff GK, Morrison WA, Kirkland MA.

ANZ J Surg. 2008 Aug;78(8):654-9. doi: 10.1111/j.1445-2197.2008.04609.x. Review.

PMID:
18796021
18.

Cost-minimisation analysis comparing gemcitabine/cisplatin, paclitaxel/carboplatin and vinorelbine/cisplatin in the treatment of advanced non-small cell lung cancer in Italy.

Novello S, Kielhorn A, Stynes G, Selvaggi G, De Marinis F, Maestri A, Foggi P, Tilden D, Tonato M, Crinò L, Rinaldi M, Migliorino AM, Scagliotti GV; Italian Lung Cancer Project Investigators.

Lung Cancer. 2005 Jun;48(3):379-87. Epub 2005 Feb 12.

PMID:
15893007

Supplemental Content

Loading ...
Support Center